<DOC>
	<DOCNO>NCT00936884</DOCNO>
	<brief_summary>The primary purpose study evaluate safety , efficacy , tolerability subcutaneous ( injection beneath skin ) MOA-728 versus placebo Asian Adult subject opioid-induced constipation advance illness</brief_summary>
	<brief_title>Study Evaluating The Efficacy And Safety Of Subcutaneous MOA-728 For The Treatment Of Opioid-Induced-Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Men woman least 18 year age , diagnosis advance illness anticipate life expectancy &gt; = 1 month ; Is receive regular dose opioids control pain ; Has diagnosis opioid induced constipation ; Is stable laxative regimen . Has know suspect mechanical gastrointestinal obstruction , potential nonopioid cause bowel dysfunction contribute constipation ; Has evidence current fecal impaction ; Has evidence active diverticulitis , peritonitis , history bowel surgery within 30 day test article administration ; Has boy weight less han 27 kg Has major illness/condition , investigator 's judgment , substantially increase risk associate subject 's participation completion study , could preclude evaluation subject 's response .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Opioid Induced Constipation</keyword>
</DOC>